Abstract | RATIONALE:
IL-22 has both proinflammatory and antiinflammatory properties. Its role in allergic lung inflammation has not been explored. OBJECTIVES: To investigate the expression and roles of IL-22 in the onset and resolution of experimental allergic asthma and its cross-talk with IL-17A. METHODS: MEASUREMENTS AND MAIN RESULTS: CONCLUSIONS:
IL-22 is required for the onset of allergic asthma, but functions as a negative regulator of established allergic inflammation. Our study reveals that IL-22 contributes to the proinflammatory properties of IL-17A in experimental allergic asthma.
|
Authors | Anne-Gaelle Besnard, Robert Sabat, Laure Dumoutier, Jean-Christophe Renauld, Monique Willart, Bart Lambrecht, Mauro M Teixeira, Sabine Charron, Lizette Fick, François Erard, Katarzyna Warszawska, Kerstin Wolk, Valerie Quesniaux, Bernhard Ryffel, Dieudonnée Togbe |
Journal | American journal of respiratory and critical care medicine
(Am J Respir Crit Care Med)
Vol. 183
Issue 9
Pg. 1153-63
(May 01 2011)
ISSN: 1535-4970 [Electronic] United States |
PMID | 21297073
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Chemokines
- Cytokines
- Interleukin-17
- Interleukins
- interleukin-22
|
Topics |
- Animals
- Asthma
(blood, immunology)
- Chemokines
(immunology)
- Cytokines
(immunology)
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Eosinophils
(immunology)
- Flow Cytometry
- Humans
- Interleukin-17
(immunology)
- Interleukins
(blood, immunology)
- Mice
- Mice, Knockout
- Th2 Cells
(immunology)
|